FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799892008> ?p ?o ?g. }

• W2799892008 endingPage "50" @default.
• W2799892008 startingPage "37" @default.
• W2799892008 abstract "Ferumoxytol is a promising non-gadolinium-based contrast agent with numerous varied magnetic resonance imaging applications. Previous reviews of vascular applications have focused primarily on cardiac and aortic applications. After considering safety concerns and technical issues, the objective of this paper is to explore peripheral applications for ferumoxytol-enhanced magnetic resonance angiography (MRA) and venography (MRV) in the upper and lower extremities. Separate searches for each of the following keywords were performed in pubmed: “ferumoxytol,” “ultrasmall superparamagnetic iron oxide,” and “USPIO.” All studies pertaining to MRA or MRV in humans are included in this review. Case-based examples of various peripheral applications are used to supplement a relatively scant literature in this space. Ferumoxytol's unique properties including high T1 relaxivity and prolonged intravascular half-life make it the optimal vascular imaging contrast agent on the market and one whose vast potential has only begun to be tapped. Ferumoxytol is a promising non-gadolinium-based contrast agent with numerous varied magnetic resonance imaging applications. Previous reviews of vascular applications have focused primarily on cardiac and aortic applications. After considering safety concerns and technical issues, the objective of this paper is to explore peripheral applications for ferumoxytol-enhanced magnetic resonance angiography (MRA) and venography (MRV) in the upper and lower extremities. Separate searches for each of the following keywords were performed in pubmed: “ferumoxytol,” “ultrasmall superparamagnetic iron oxide,” and “USPIO.” All studies pertaining to MRA or MRV in humans are included in this review. Case-based examples of various peripheral applications are used to supplement a relatively scant literature in this space. Ferumoxytol's unique properties including high T1 relaxivity and prolonged intravascular half-life make it the optimal vascular imaging contrast agent on the market and one whose vast potential has only begun to be tapped." @default.
• W2799892008 created "2018-05-17" @default.
• W2799892008 creator A5013188973 @default.
• W2799892008 creator A5030822917 @default.
• W2799892008 creator A5072458448 @default.
• W2799892008 creator A5084751608 @default.
• W2799892008 date "2019-01-01" @default.
• W2799892008 modified "2023-10-18" @default.
• W2799892008 title "Ferumoxytol-enhanced MRI in the peripheral vasculature" @default.
• W2799892008 cites W1830656716 @default.
• W2799892008 cites W1854586816 @default.
• W2799892008 cites W1890470412 @default.
• W2799892008 cites W1918222234 @default.
• W2799892008 cites W1923763620 @default.
• W2799892008 cites W1937451961 @default.
• W2799892008 cites W1967202129 @default.
• W2799892008 cites W1974023961 @default.
• W2799892008 cites W1976111275 @default.
• W2799892008 cites W1984232298 @default.
• W2799892008 cites W1999531099 @default.
• W2799892008 cites W2015182248 @default.
• W2799892008 cites W2019613901 @default.
• W2799892008 cites W2022280660 @default.
• W2799892008 cites W2031054493 @default.
• W2799892008 cites W2050825229 @default.
• W2799892008 cites W2069746446 @default.
• W2799892008 cites W2098679547 @default.
• W2799892008 cites W2136516663 @default.
• W2799892008 cites W2150041194 @default.
• W2799892008 cites W2153714499 @default.
• W2799892008 cites W2161136265 @default.
• W2799892008 cites W2163203871 @default.
• W2799892008 cites W2170292869 @default.
• W2799892008 cites W2203570087 @default.
• W2799892008 cites W2286395366 @default.
• W2799892008 cites W2287939536 @default.
• W2799892008 cites W2315152480 @default.
• W2799892008 cites W2317019069 @default.
• W2799892008 cites W2322884383 @default.
• W2799892008 cites W2335276977 @default.
• W2799892008 cites W2395662292 @default.
• W2799892008 cites W2493444894 @default.
• W2799892008 cites W2509266299 @default.
• W2799892008 cites W2555320571 @default.
• W2799892008 cites W2567572599 @default.
• W2799892008 cites W2582245763 @default.
• W2799892008 cites W2583541069 @default.
• W2799892008 cites W2607015440 @default.
• W2799892008 cites W2613700522 @default.
• W2799892008 cites W2621727327 @default.
• W2799892008 cites W263771170 @default.
• W2799892008 cites W2729798514 @default.
• W2799892008 doi "https://doi.org/10.1016/j.crad.2018.02.021" @default.
• W2799892008 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7437525" @default.
• W2799892008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29731126" @default.
• W2799892008 hasPublicationYear "2019" @default.
• W2799892008 type Work @default.
• W2799892008 sameAs 2799892008 @default.
• W2799892008 citedByCount "21" @default.
• W2799892008 countsByYear W27998920082018 @default.
• W2799892008 countsByYear W27998920082019 @default.
• W2799892008 countsByYear W27998920082020 @default.
• W2799892008 countsByYear W27998920082021 @default.
• W2799892008 countsByYear W27998920082022 @default.
• W2799892008 countsByYear W27998920082023 @default.
• W2799892008 crossrefType "journal-article" @default.
• W2799892008 hasAuthorship W2799892008A5013188973 @default.
• W2799892008 hasAuthorship W2799892008A5030822917 @default.
• W2799892008 hasAuthorship W2799892008A5072458448 @default.
• W2799892008 hasAuthorship W2799892008A5084751608 @default.
• W2799892008 hasBestOaLocation W27998920082 @default.
• W2799892008 hasConcept C126322002 @default.
• W2799892008 hasConcept C126838900 @default.
• W2799892008 hasConcept C141071460 @default.
• W2799892008 hasConcept C143409427 @default.
• W2799892008 hasConcept C164705383 @default.
• W2799892008 hasConcept C191897082 @default.
• W2799892008 hasConcept C192562407 @default.
• W2799892008 hasConcept C2778212899 @default.
• W2799892008 hasConcept C2778269268 @default.
• W2799892008 hasConcept C2780643987 @default.
• W2799892008 hasConcept C2780868729 @default.
• W2799892008 hasConcept C2909801847 @default.
• W2799892008 hasConcept C2910094404 @default.
• W2799892008 hasConcept C2911171252 @default.
• W2799892008 hasConcept C46762472 @default.
• W2799892008 hasConcept C557651011 @default.
• W2799892008 hasConcept C71924100 @default.
• W2799892008 hasConceptScore W2799892008C126322002 @default.
• W2799892008 hasConceptScore W2799892008C126838900 @default.
• W2799892008 hasConceptScore W2799892008C141071460 @default.
• W2799892008 hasConceptScore W2799892008C143409427 @default.
• W2799892008 hasConceptScore W2799892008C164705383 @default.
• W2799892008 hasConceptScore W2799892008C191897082 @default.
• W2799892008 hasConceptScore W2799892008C192562407 @default.
• W2799892008 hasConceptScore W2799892008C2778212899 @default.
• W2799892008 hasConceptScore W2799892008C2778269268 @default.
• W2799892008 hasConceptScore W2799892008C2780643987 @default.

• next